Arulkumaran Shanmugam, Ramprasath Vanu Ramkumar, Shanthi Palanivelu, Sachdanandam Panchanatham
Department of Medical Biochemistry, Dr. ALM. Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai, 600113, India.
Mol Cell Biochem. 2006 Oct;291(1-2):77-82. doi: 10.1007/s11010-006-9199-2. Epub 2006 Sep 5.
Cancer prevention and treatment using phytochemicals have attracted increased interest. Recent studies have shown that Semecarpus anacardium Linn nut milk extract (SA), a promising antioxidant and anticancer drug, exerts its anticancer effect through reducing or quenching reactive oxygen species under different conditions. The present study examined whether Phyllanthus emblica Linn fruit, rich in vitamin C content synergistically in combination can enhance both the antioxidant and anticancer activity of S. anacardium nut milk extract in 7, 12-dimethyl benz[a]anthracene (DMBA)-induced experimental mammary carcinoma in rat model. Female Sprague Dawley rats of 180 +/- 10 g were categorized into six groups. Three groups were administered DMBA (25mg/rat, orally) dissolved in olive oil to induce mammary carcinoma. One of these groups received Kalpaamruthaa (KA) (300 mg/kg b.wt, orally) and other group received SA (200mg/kg b.wt, orally) for 14 days after 90 days of DMBA induction. A vehicle treated control and drug control groups were also included. The mitochondrial fraction of untreated DMBA-induced mammary gland showed 2.61-fold increase in lipid peroxidation level and abnormal changes in the activities/levels of mitochondrial enzymic (superoxide dismutase, glutathione peroxidase and glutathione reductase) and non-enzymic (glutathione, vitamin C and vitamin E) antioxidants were observed. DMBA treated rats also showed decline in the activities of mitochondrial enzymes such as succinate dehydrogenase, malate dehydrogenase, alpha-ketoglutarate dehydrogenase and isocitrate dehydrogenase. In contrast, rats treated with Kalpaamruthaa showed normal lipid peroxide level and antioxidant defenses. The results of the present study highlight the improved antioxidant property of KA than sole treatment of S. anacardium nut milk extract.
使用植物化学物质进行癌症预防和治疗已引起越来越多的关注。最近的研究表明,印度没药树坚果乳提取物(SA)是一种很有前景的抗氧化剂和抗癌药物,它在不同条件下通过减少或淬灭活性氧来发挥其抗癌作用。本研究检测了富含维生素C的余甘子果实与印度没药树坚果乳提取物联合使用时,是否能协同增强其在7,12-二甲基苯并[a]蒽(DMBA)诱导的大鼠实验性乳腺癌模型中的抗氧化和抗癌活性。将体重为180±10克的雌性斯普拉格-道利大鼠分为六组。三组大鼠口服溶解于橄榄油中的DMBA(25毫克/只)以诱导乳腺癌。其中一组在DMBA诱导90天后接受Kalpaamruthaa(KA)(300毫克/千克体重,口服),另一组接受SA(200毫克/千克体重,口服),持续14天。还包括一个溶剂处理对照组和一个药物对照组。未处理的DMBA诱导的乳腺线粒体部分显示脂质过氧化水平增加2.61倍,并且观察到线粒体酶(超氧化物歧化酶、谷胱甘肽过氧化物酶和谷胱甘肽还原酶)和非酶(谷胱甘肽、维生素C和维生素E)抗氧化剂的活性/水平发生异常变化。DMBA处理的大鼠还显示出线粒体酶如琥珀酸脱氢酶、苹果酸脱氢酶、α-酮戊二酸脱氢酶和异柠檬酸脱氢酶的活性下降。相比之下,用Kalpaamruthaa处理的大鼠显示脂质过氧化物水平和抗氧化防御正常。本研究结果突出了KA比单独使用印度没药树坚果乳提取物具有更好的抗氧化性能。